Quantum BioPharma Files $700M Lawsuit Against CIBC and RBC for Market Manipulation
Quantum BioPharma, previously known as FSD Pharma, is making waves in the news with a US$700M+ lawsuit against CIBC World Markets, RBC Dominion Securities, and others. They’re claiming market manipulation and share price spoofing. What does this mean for investors? Well, Quantum BioPharma has rallied legal teams to tackle this on a contingency basis, which is great news because it means no upfront costs for the company.
If you’re a shareholder who suffered losses during the relevant period, Quantum BioPharma is reaching out to you. They want to hear about your trading losses and personal impact to strengthen their case. You can easily share your information via email or through their website.
It’s always fascinating to see how companies are standing up against alleged misconduct in the financial world. Quantum BioPharma is taking a bold step, and shareholders have the opportunity to join hands with them in this legal battle. Let’s see where this lawsuit takes us in the realm of securities and exchange news.
